Novartis gets approval for first malaria drug for babies and children
Eight African countries who participated in the assessment are now expected to issue quick approvals for the treatment, which is also known as Riamet Baby in some countries.
Novartis launched Coartem to treat malaria in 1999, with a new dose strength now designed for small babies. The treatment is dissolvable, including in breast milk, and has a sweet cherry flavour to make it easier to administer.
Until now, there has been no approved malaria treatment for infants weighing less than 4.5 kilograms, leaving a treatment gap, Novartis said.
The eight countries that took part in the assessment were Burkina Faso, Cote d'Ivoire, Kenya, Malawi, Mozambique, Nigeria, Tanzania and Uganda. Around 30 million babies are born in areas of malaria risk in Africa every year, with one survey across West Africa reporting infections ranging between 3.4% and 18.4% in infants younger than six months old, Novartis said.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
7 hours ago
- Time of India
Prostate cancer: 7 myths that can delay cancer diagnosis in men
When it comes to men's health, prostate cancer tends to fly under the radar—until it doesn't. Prostate cancer is one of the most common cancers in American men, second only to skin cancer. And yet, myths and misunderstandings still cloud how we talk about it, test for it, and treat it. From the idea that it only affects "older guys" to the belief that early signs of prostate cancer always come with obvious symptoms (spoiler: they usually don't), misinformation can be dangerous. Worse, it often leads to delays in diagnosis and prostate cancer treatment—and time matters when dealing with any cancer. Whether you're in your 40s or your 70s, knowing the facts about prostate health is just smart self-care. What is Prostate Cancer? Prostate cancer starts in the prostate gland, a small, walnut-sized part of the male reproductive system that sits just below the bladder. But sometimes, the cells in the prostate start growing out of control. That's when cancer kicks in. The tricky part is that prostate cancer symptoms often don't show up early. Most guys feel totally fine, no pain, no warning signs, nothing. That's why regular prostate cancer screening, including PSA tests and yes, the digital rectal exam, matter. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Indonesia: Unsold Sofas Prices May Surprise You (Prices May Surprise You) Sofas | Search Ads Search Now Undo In many cases, prostate cancer is highly treatable, especially when caught early. But if left undetected, it can spread to bones, lymph nodes, and other areas. That's why keeping tabs on your prostate health, especially after age 50, is a game-changer. Think of it as part of long-term men's cancer awareness—your future self will thank you. Myth: 'If I don't have symptoms, I don't have prostate cancer.' Sorry, wish it were true! The sneaky thing about prostate cancer is that in the early stages, it usually has no symptoms at all. Nope, not even a twinge or a peep. When symptoms like trouble peeing or back pain do pop up, it usually means the cancer has already advanced. That's why screening and talking to your doc (even when you feel perfectly fine) is so important, especially if you're over 50, African-American, or have a family history of prostate cancer. Myth: 'Only old men get prostate cancer.' Sure, risk increases as you get older—most cases happen in men over 65. But younger men can and do get prostate cancer, sometimes even in their forties or fifties. Bottom line: age is a big risk factor, but it's not a guarantee. No matter your age, be aware of your personal risk and talk it over with your health provider. Myth: 'If my dad had it, I'm doomed.' Having a father (or brother) with prostate cancer definitely bumps up your risk—about double, in fact. But it's not destiny; plenty of men with a strong family history never get prostate cancer. And on the flip side, about 90% of prostate cancers pop up in men with no family history at all. Your family history is important to know, but it's not a crystal ball. Myth: 'Screenings and PSA tests are pointless (or will always lead to unnecessary treatment).' Screening is controversial, but it's not pointless! The PSA (prostate-specific antigen) blood test can catch cancer before symptoms show up, but it's not foolproof. Some cancers are slow, harmless guests; others need action, fast. If you have an elevated PSA, that's just one piece of the puzzle, not an automatic cancer diagnosis or reason to rush into treatment. Decisions should always be personal, based on your age, health, and family history—and in conversation with your doctor. Myth: 'If I have prostate cancer, I need treatment right now.' Not all prostate cancers are aggressive or dangerous. Some are so slow-growing that your doctor may recommend 'active surveillance'—keep an eye on things with regular tests and only step in if the situation changes. For many men, avoiding or delaying treatment means fewer side effects, while still staying safe. Myth: 'Treatments always ruin your sex life and cause incontinence.' Treatments can have side effects, including trouble with erections and urinary issues—you've probably heard this a lot. But not every guy who gets treated ends up with long-term problems. Side effects depend on many factors: your age, the specific treatment, and even the experience of your healthcare team. Plus, treatments and support to help manage side effects are better than ever. Myth: 'If you don't eat sugar or take special vitamins, you won't get prostate cancer.' Let's clear the air: eating sugar doesn't cause prostate cancer, and there's no magic diet or supplement that can prevent it. Obesity is linked to a higher risk of several cancers, including prostate, so eating healthy matters, but skipping sugar or popping vitamins won't give you a get-out-of-cancer card.
Economic Times
4 days ago
- Economic Times
Can genetics predict obesity? New study may help spot risk in kids before it is too late
Synopsis A new study introduces ancestry-specific polygenic risk scores that double the effectiveness of predicting adult obesity risk compared to current methods. Analyzing genetic data from over 5 million individuals, the tool identifies those at risk early in childhood. While genetics play a role, lifestyle and environmental factors remain crucial in addressing the global obesity epidemic. iStock A new study introduces ancestry-specific polygenic risk scores that double the effectiveness of predicting adult obesity risk compared to current methods. (Image :iStock) Imagine knowing whether your child may be at risk for obesity—not years after weight gain begins, but long before it shows. A groundbreaking new study published in Nature Medicine suggests this could soon be possible, thanks to a genetic tool called polygenic risk scores (PGS).Led by over 600 scientists from 500 institutions worldwide, and drawing data from The Genetic Investigation of ANthropometric Traits (GIANT) consortium and 23andMe, the study analyzed genetic information from more than 5 million individuals. Their goal? To develop a more precise way to predict a person's likelihood of developing obesity, starting from childhood. Current obesity risk tools largely rely on family history, diet, and lifestyle. But this study's new ancestry-specific and multi-ancestry polygenic risk scores proved about twice as effective in predicting obesity in adulthood compared to existing people of European ancestry, for example, the score accounted for 17.6% of an individual's risk of developing a high Body Mass Index (BMI)—a key indicator of obesity. The study included a broad participant base: 70% had European ancestry, 14.4% were Hispanic, 8.4% East Asian, 4.6% African, and 1.5% South while the tool is promising, it isn't a crystal ball. 'Obesity is not only about genetics,' said Dr. Ruth Loos, study co-author and professor at the University of Copenhagen's Novo Nordisk Foundation Center, in an interview with NBC News. 'Genetics alone can never accurately predict obesity… other factors, such as lifestyle, need to be part of the predictions.' The urgency behind such research is clear. Obesity is now considered one of the world's fastest-growing public health threats. According to World Health Organization (WHO) data: In 2022, 2.5 billion adults were overweight, including over 890 million with obesity. Childhood obesity is skyrocketing—35 million children under five were overweight in 2024, and over 390 million adolescents aged 5–19 were overweight in 2022. Obesity was a factor in 3.7 million global deaths in 2021 alone. Perhaps more troubling is the shift in obesity prevalence from wealthier nations to low- and middle-income countries, where children face a 'double burden' of both undernutrition and rising obesity rates. The WHO warns that these children often live in environments where high-calorie, nutrient-poor foods are cheap and accessible, but healthier choices and safe spaces for exercise are is much more than a number on a scale. It increases the risk of nearly 200 diseases, including type 2 diabetes, cardiovascular disease, asthma, and certain cancers. For children, the stakes are even higher: obesity not only impacts their physical and mental health but also academic performance and social wellbeing due to stigma and childhood obesity often carries into adulthood, setting the stage for chronic illness and shorter lifespans. 'Children with obesity are very likely to be adults with obesity,' notes the WHO. While genetic scores like the one developed in this study could revolutionize early detection, experts caution that there's no one-size-fits-all solution. Dr. Karen Hacker, director of the CDC's National Center for Chronic Disease Prevention, told USA TODAY that effective obesity prevention must address broader social determinants of health—including access to healthcare, nutritious food, physical activity, and Centers for Disease Control and Prevention (CDC) recommends multifaceted strategies: from medication and surgery for treatment, to policy-driven efforts ensuring access to healthy food, safe physical environments, and stigma-free support systems.
Time of India
4 days ago
- Time of India
Can genetics predict obesity? New study may help spot risk in kids before it is too late
Imagine knowing whether your child may be at risk for obesity—not years after weight gain begins, but long before it shows. A groundbreaking new study published in Nature Medicine suggests this could soon be possible, thanks to a genetic tool called polygenic risk scores (PGS). Led by over 600 scientists from 500 institutions worldwide, and drawing data from The Genetic Investigation of ANthropometric Traits (GIANT) consortium and 23andMe, the study analyzed genetic information from more than 5 million individuals. Their goal? To develop a more precise way to predict a person's likelihood of developing obesity, starting from childhood. Explore courses from Top Institutes in Please select course: Select a Course Category PGDM Public Policy Degree Artificial Intelligence Project Management Finance healthcare Digital Marketing Technology Leadership Data Science others MBA MCA Others Data Analytics CXO Healthcare Cybersecurity Data Science Management Product Management Operations Management Design Thinking Skills you'll gain: Financial Analysis & Decision Making Quantitative & Analytical Skills Organizational Management & Leadership Innovation & Entrepreneurship Duration: 24 Months IMI Delhi Post Graduate Diploma in Management (Online) Starts on Sep 1, 2024 Get Details What the Study Found Current obesity risk tools largely rely on family history, diet, and lifestyle. But this study's new ancestry-specific and multi-ancestry polygenic risk scores proved about twice as effective in predicting obesity in adulthood compared to existing assessments. In people of European ancestry, for example, the score accounted for 17.6% of an individual's risk of developing a high Body Mass Index (BMI)—a key indicator of obesity. The study included a broad participant base: 70% had European ancestry, 14.4% were Hispanic, 8.4% East Asian, 4.6% African, and 1.5% South Asian. But while the tool is promising, it isn't a crystal ball. 'Obesity is not only about genetics,' said Dr. Ruth Loos, study co-author and professor at the University of Copenhagen's Novo Nordisk Foundation Center, in an interview with NBC News. 'Genetics alone can never accurately predict obesity… other factors, such as lifestyle, need to be part of the predictions.' You Might Also Like: This one food habit could shield you from arthritis, obesity and diabetes. Science backs what Indian kitchens always knew The Global Obesity Epidemic The urgency behind such research is clear. Obesity is now considered one of the world's fastest-growing public health threats. According to World Health Organization (WHO) data: In 2022, 2.5 billion adults were overweight, including over 890 million with obesity. Childhood obesity is skyrocketing—35 million children under five were overweight in 2024, and over 390 million adolescents aged 5–19 were overweight in 2022. Obesity was a factor in 3.7 million global deaths in 2021 alone. Perhaps more troubling is the shift in obesity prevalence from wealthier nations to low- and middle-income countries, where children face a 'double burden' of both undernutrition and rising obesity rates. The WHO warns that these children often live in environments where high-calorie, nutrient-poor foods are cheap and accessible, but healthier choices and safe spaces for exercise are not. Why Early Detection Matters Obesity is much more than a number on a scale. It increases the risk of nearly 200 diseases, including type 2 diabetes, cardiovascular disease, asthma, and certain cancers. For children, the stakes are even higher: obesity not only impacts their physical and mental health but also academic performance and social wellbeing due to stigma and bullying. Importantly, childhood obesity often carries into adulthood, setting the stage for chronic illness and shorter lifespans. 'Children with obesity are very likely to be adults with obesity,' notes the WHO. You Might Also Like: Are you really obese? Experts challenge BMI as only measure of obesity, propose new guidelines for better health What Can Be Done? While genetic scores like the one developed in this study could revolutionize early detection, experts caution that there's no one-size-fits-all solution. Dr. Karen Hacker, director of the CDC's National Center for Chronic Disease Prevention, told USA TODAY that effective obesity prevention must address broader social determinants of health—including access to healthcare, nutritious food, physical activity, and education. The Centers for Disease Control and Prevention (CDC) recommends multifaceted strategies: from medication and surgery for treatment, to policy-driven efforts ensuring access to healthy food, safe physical environments, and stigma-free support systems.
